The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Drug delivery to the posterior segment of the eye
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phase transition in polymer gels induced by visible light
Suzuki, A., & Tanaka, T. (1990) · Nature · doi:10.1038/346345a0 · Cited by 1,035
Fluocinolone Acetonide Implant (Retisert) for Noninfectious Posterior Uveitis
Jaffe, G. J., Martin, D., Callanan, D., Pearson, P. A., Levy, B., & Comstock, T. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.021 · Cited by 454
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 414
Topical and systemic drug delivery to the posterior segments
HUGHES, P., OLEJNIK, O., CHANGLIN, J., & WILSON, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.004 · Cited by 400
(2000) · PubMed · Cited by 358
Bourges, J.-L., Gautier, S. E., Delie, F., Bejjani, R. A., Jeanny, J.-C., Gurny, R., BenEzra, D., & Behar-Cohen, F. F. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1068 · Cited by 357
Inner limiting membrane barriers to aav-mediated retinal transduction from the vitreous
Dalkara, D., Kolstad, K. D., Caporale, N., Visel, M., Klimczak, R. R., Schaffer, D. V., & Flannery, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.181 · Cited by 357
Human sclera: Thickness and surface area
Olsen, T. W., Aaberg, S. Y., Geroski, D. H., & Edelhauser, H. F. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)80096-8 · Cited by 349
Mannermaa, E., Vellonen, K.-S., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 349
Ghate, D., & Edelhauser, H. F. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.275 · Cited by 329
Ocular Preparations: The Formulation Approach
Pal Kaur, I., & Kanwar, M. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120003445 · Cited by 310
Ocular novel drug delivery: impacts of membranes and barriers
Barar, J., Javadzadeh, A. R., & Omidi, Y. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.5.567 · Cited by 308
Cell culture models of the ocular barriers
Hornof, M., Toropainen, E., & Urtti, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.01.009 · Cited by 300
Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir Implant
Musch, D. C., Martin, D. F., Gordon, J. F., Davis, M. D., & Kuppermann, B. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370203 · Cited by 286
Transscleral drug delivery for posterior segment disease
Geroski, D. H., & Edelhauser, H. F. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00193-4 · Cited by 282
Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
Hämäläinen, K. M., Kananen, K., Auriola, S. O. K., Kontturi, K., & Urtti, A. O. (1997) · PubMed · Cited by 266
Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and Lipophilicity
Pitka¨nen, L., Ranta, V.-P., Moilanen, H., & Urtti, A. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1051 · Cited by 261
Periocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257
INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS
PEYMAN, G. A., LAD, E. M., & MOSHFEGHI, D. M. (2009) · Retina · doi:10.1097/iae.0b013e3181a94f01 · Cited by 255
Gold nanoparticles enable selective light-induced contents release from liposomes
Paasonen, L., Laaksonen, T., Johans, C., Yliperttula, M., Kontturi, K., & Urtti, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.009 · Cited by 252
Drug delivery to the retina: challenges and opportunities
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.1.45 · Cited by 249
Perry, C. M., & Barman Balfour, J. A. (1999) · Drugs · doi:10.2165/00003495-199957030-00010 · Cited by 243
Kompella, U. B., Bandi, N., & Ayalasomayajula, S. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0791 · Cited by 239
Intraocular implants for extended drug delivery: Therapeutic applications
Bourges, J. L., Bloquel, C., Thomas, A., Froussart, F., Bochot, A., Azan, F., Gurny, R., BenEzra, D., & Behar-Cohen, F. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.026 · Cited by 235
Olsen, T. W., Edelhauser, H. F., Lim, J. I., & Geroski, D. H. (1995) · PubMed · Cited by 230
Iontophoresis: A non-invasive ocular drug delivery
Eljarrat-Binstock, E., & Domb, A. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.049 · Cited by 216
The blood–retinal barriers system. Basic concepts and clinical evaluation
Cunha-Vaz, J. G. (2004) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00213-6 · Cited by 214
Novel approaches to retinal drug delivery
Janoria, K. G., Gunda, S., Boddu, S. H., & Mitra, A. K. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.371 · Cited by 213
Intrascleral Drug Delivery to the Eye Using Hollow Microneedles
Jiang, J., Moore, J. S., Edelhauser, H. F., & Prausnitz, M. R. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9756-3 · Cited by 208
Transscleral delivery of bioactive protein to the choroid and retina.
Ambati, J., Gragoudas, E. S., Miller, J. W., You, T., Miyamoto, K., Delori, F. C., & Adamis, A. P. (2000) · PubMed · Cited by 207
Ideta, R., Tasaka, F., Jang, W.-D., Nishiyama, N., Zhang, G.-D., Harada, A., Yanagi, Y., Tamaki, Y., Aida, T., & Kataoka, K. (2005) · Nano Letters · doi:10.1021/nl051679d · Cited by 196
Applications of Liposomes in Ophthalmology
Ebrahim, S., Peyman, G. A., & Lee, P. J. (2005) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2004.12.006 · Cited by 193
High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection
Weijtens, O., Feron, E. J., Schoemaker, R. C., Cohen, A. F., Lentjes, E. G. W. M., Romijn, F. P. H. T. M., & van Meurs, J. C. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00129-4 · Cited by 188
Nanoparticles for gene delivery to retinal pigment epithelial cells.
Bejjani, R. A., BenEzra, D., Cohen, H., Rieger, J., Andrieu‐Soler, C., Jeanny, J., Gollomb, G., & Béhar‐Cohen, F. (2005) · PubMed · Cited by 176
Transport Barriers in Transscleral Drug Delivery for Retinal Diseases
Kim, S. H., Lutz, R. J., Wang, N. S., & Robinson, M. R. (2007) · Ophthalmic Research · doi:10.1159/000108117 · Cited by 172
Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment
Olsen, T. W., Feng, X., Wabner, K., Conston, S. R., Sierra, D. H., Folden, D. V., Smith, M. E., & Cameron, J. D. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.05.045 · Cited by 171
Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic)Acid Microspheres
Carrasquillo, K. G., Ricker, J. A., Rigas, I. K., Miller, J. W., Gragoudas, E. S., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.01-1156 · Cited by 163
Transscleral drug delivery to the posterior eye: Prospects of pharmacokinetic modeling
Ranta, V.-P., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.025 · Cited by 160
Iluvien ™ : a new sustained delivery technology for posterior eye disease
Kane, F. E., Burdan, J., Cutino, A., & Green, K. E. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.9.1039 · Cited by 158
Colloidal Carriers for Ophthalmic Drug Delivery
Mainardes, R. M., Urban, M. C. C., Cinto, P. O., Khalil, N. M., Chaud, M. V., Evangelista, R. C., & Gremião, M. P. D. (2005) · Current Drug Targets · doi:10.2174/1389450053765914 · Cited by 155
Review: Practical Issues in Intravitreal Drug Delivery
Maurice, D. M. (2001) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076801753162807 · Cited by 153
Robinson, M. R., Lee, S. S., Kim, H., Kim, S., Lutz, R. J., Galbán, C. J., Bungay, P. M., Yuan, P., Wang, N. S., Kim, J., et al. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.08.007 · Cited by 142
Ayalasomayajula, S. P., & Kompella, U. B. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.019 · Cited by 141
Kim, H. C., Robinson, M. R., Lizak, M. J., Tansey, G., Lutz, R. J., Yuan, P., Wang, N. S., & Csaky, K. G. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0091 · Cited by 129
Biodegradable Intraocular Therapies for Retinal Disorders: Progress to Date
Kuno, N., & Fujii, S. (2010) · Drugs & Aging · doi:10.2165/11530970-000000000-00000 · Cited by 127
Amrite, A. C., Edelhauser, H. F., Singh, S. R., & Kompella, U. B. (2008) · PubMed Central · Cited by 125
Transscleral drug delivery to the retina and choroid
Ambati, J., & Adamis, A. P. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00018-0 · Cited by 119
Weijtens, O., van der Sluijs, F. A., Schoemaker, R. C., Lentjes, E. G. W. M., Cohen, A. F., Romijn, F. P. H. T. M., & MEURS, J. C. V. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70131-x · Cited by 115
Moshfeghi, A., & Peyman, G. A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.006 · Cited by 98
Drug delivery methods for posterior segment disease
Hsu, J. (2007) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3281108000 · Cited by 97
dos Santos, A. L. G., Bochot, A., Doyle, A., Tsapis, N., Siepmann, J., Siepmann, F., Schmaler, J., Besnard, M., Béhar‐Cohen, F., & Fattal, E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.010 · Cited by 96
Saishin, Y., Silva, R. L., Saishin, Y., Callahan, K. P., Schoch, C., Ahlheim, M., Lai, H. C., Kane, F. E., Brazzell, R. K., Bodmer, D., et al. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0600 · Cited by 94
Pharmacokinetics of Intraocular Drug Delivery by Periocular Injections Using Ocular Fluorophotometry
Ghate, D. A., Brooks, W., McCarey, B. E., & Edelhauser, H. F. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0954 · Cited by 93
Kinetics of macromolecules injected into the subretinal space
Marmor, M. F., Negi, A., & Maurice, D. M. (1985) · Experimental Eye Research · doi:10.1016/0014-4835(85)90138-1 · Cited by 91
Tolerance of Ocular Iontophoresis in Healthy Volunteers
Parkinson, T. M., Ferguson, E. H., Febbraro, S., Bakhtyari, A., King, M., & Mundasad, M. (2003) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076803321637672 · Cited by 91
Laude, A., Tan, L. E., WILSON, C. G., Lascaratos, G., Elashri, M., Aslam, T. M., Patton, N., & Dhillon, B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.003 · Cited by 85
NT-501: an ophthalmic implant of polymer-encapsulated ciliary neurotrophic factor-producing cells.
Emerich, D. F., & Thanos, C. G. (2008) · PubMed · Cited by 85
Movement of Albumin and Dextran Through the Sclera
Bill, A. (1965) · Archives of Ophthalmology · doi:10.1001/archopht.1965.00970040250024 · Cited by 82
Biodegradable Intrascleral Implant for Sustained Intraocular Delivery of Betamethasone Phosphate
Okabe, J., Kimura, H., Kunou, N., Okabe, K., Kato, A., & Ogura, Y. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0375 · Cited by 82
Ophthalmic light sensitive nanocarrier systems
Christie, J. G., & Kompella, U. B. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.12.005 · Cited by 81
Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems
Lee, S.-B., Geroski, D. H., Prausnitz, M. R., & Edelhauser, H. F. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00211-2 · Cited by 79
The Effect of Hydration and Matrix Composition on Solute Diffusion in Rabbit Sclera
Boubriak, O., Urban, J., Akhtar, S., Meek, K. M., & Bron, A. J. (2000) · Experimental Eye Research · doi:10.1006/exer.2000.0909 · Cited by 76
Iontophoresis: from the lab to the bed side
Halhal, M., Renard, G. J., Courtois, Y., et al. (2003) · Experimental Eye Research · doi:10.1016/j.exer.2003.10.017 · Cited by 76
Feasibility of Drug Delivery to the Posterior Pole of the Rabbit Eye with an Episcleral Implant
Kato, A., Kimura, H., Okabe, K., Okabe, J., Kunou, N., & Ogura, Y. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1258 · Cited by 66
Novel Drug Delivery Systems for Retinal Diseases
Lee, S. S., & Robinson, M. R. (2009) · Ophthalmic Research · doi:10.1159/000209665 · Cited by 65
Photosensitizer delivery for photodynamic therapy of choroidal neovascularization
Renno, R. Z., & Miller, J. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00195-8 · Cited by 64
Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment
Wang, Y., Challa, P., Epstein, D. L., & Yuan, F. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.10.075 · Cited by 61
Delivery from Episcleral Exoplants
Carvalho, R. A. P. D., Krausse, M. L., Murphree, A. L., Schmitt, E. E., Campochiaro, P. A., & Maumenee, I. H. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0030 · Cited by 60
The effect of intraocular pressure on human and rabbit scleral permeability.
Rudnick, D. E., Noonan, J. S., Geroski, D. H., Prausnitz, M. R., & Edelhauser, H. F. (1999) · PubMed · Cited by 57
Pitkänen, L., Ranta, V., Moilanen, H., & Urtti, A. O. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9342-0 · Cited by 56
dos Santos, A. L. G., Bochot, A., Tsapis, N., Artzner, F., Bejjani, R. A., Thillaye-Goldenberg, B., de Kozak, Y., Fattal, E., & Béhar‐Cohen, F. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9748-0 · Cited by 52
Molokhia, S. A., Jeong, E., Higuchi, W. I., & Li, S. K. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.10.010 · Cited by 49
Intraocular Penetration Kinetics of Prednisolone after Subconjunctival Injection in Rabbits
Tsuji, A., Tamai, I., & Sasaki, K. (2009) · Ophthalmic Research · doi:10.1159/000266253 · Cited by 48
Intravitreal pegaptanib sodium (Macugen®) for diabetic macular oedema
Querques, G., Bux, A. V., Martinelli, D., Iaculli, C., & Noci, N. D. (2009) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2009.01580.x · Cited by 46
Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix
Gilbert, J. A., Simpson, A. E., Rudnick, D. E., Geroski, D. H., Aaberg, T. M., & Edelhauser, H. F. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00151-2 · Cited by 44
Conrad, J. M., & Robinson, J. R. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600690806 · Cited by 43
Recent Patents on Ocular Drug Delivery Systems
Conway, B. R. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108783331410 · Cited by 42
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
Normand, N., Valamanesh, F., Savoldelli, M., Mascarelli, F., BenEzra, D., Courtois, Y., & Béhar‐Cohen, F. (2005) · PubMed · Cited by 41
A histopathologic study of retinal lesions inflicted by transscleral iontophoresis
Lam, T. T., Fu, J., & Tso, M. O. M. (1991) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf00170699 · Cited by 39
Zignani, M., Einmahl, S., Baeyens, V., Varesio, E., Veuthey, J. L., Anderson, J., Heller, J., Tabatabay, C., & Gurny, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00107-7 · Cited by 39
Davies, J. B., Ciavatta, V. T., Boatright, J. H., & Nickerson, J. M. (2003) · PubMed · Cited by 30
Posterior Juxtascleral Depot Administration of Anecortave Acetate
Kaiser, P. K., Goldberg, M. F., & Davis, A. A. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.10.015 · Cited by 24
The Effects of Intravitreal Ophthalmic Medications on Intraocular Pressure
Wu, H., & Chen, T. C. (2009) · Seminars in Ophthalmology · doi:10.1080/08820530902800397 · Cited by 22
Cited by
Lipid nanoparticles for nucleic acid delivery: Current perspectives
Samaridou, E., Heyes, J., & Lutwyche, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.002 · Cited by 583
Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481
Microneedle, bio-microneedle and bio-inspired microneedle: A review
Ma, G., & Wu, C. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.011 · Cited by 477
Varela-Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García-Otero, X., Luzardo-Álvarez, A., Fernández-Ferreiro, A., & Otero-Espinar, F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030269 · Cited by 354
Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo
Xu, Q., Boylan, N. J., Suk, J. S., Wang, Y.-Y., Nance, E. A., Yang, J.-C., McDonnell, P. J., Cone, R. A., Duh, E. J., & Hanes, J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.018 · Cited by 326
Metadata
- Authors
- Thrimawithana, T. R., Young, S., Bunt, C. R., Green, C., & Alany, R. G.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 16
- Issue
- 5-6
- Pages
- 270-277
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2147842670
- Cited by
- 335
- References
- 83
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.